July 7, 2014 the FDA approved antifungal Tavaborole. Tabavorole is bright ceramide transfer RNA synthetase (Leucyl-transfer RNA synthetase) inhibitor, is the key enzyme of fungal protein synthesis. Clinical use of a 5% solution for the treatment of nail fungus (Onychomycosis). Tavaborole trade name Kerydin, developed by Anacor Pharmaceuticals. Tavaborole is the first boron oxygen for the treatment of toenail infections olane (oxaborole) antifungal, Tavaborole indications for toenail fungus Trichophyton rubrum or Trichophyton rubrum infections. Instructions recommended once a day for toenail infections, treatment for 48 weeks, according to the proposal Anacor, and do not need to nail debridement.